Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2018-08-15 Earnings Release
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
Zur Rose Group records 30 percent sales growth in first half of 2018
Earnings Release Classification · 100% confidence The document explicitly details the company's financial performance for the 'first half of 2018', including consolidated sales, operating results (EBITDA), and net income/loss for the period January 1st to June 30th, 2018. It contains detailed segment breakdowns (Switzerland, Germany) and financial tables covering the half-year period. This content aligns perfectly with the definition of a comprehensive financial report for a period shorter than a year, which corresponds to the Interim / Quarterly Report (IR) category. Although it mentions a presentation is available, the core content provided is the results summary itself, not just an announcement of the report's release. H1 2018
2018-08-15 English
Presentation on the half-year results 2018
Investor Presentation Classification · 98% confidence The document is titled "H1 2018 Results Conference Call" and contains detailed slides covering a Business Update, Financial Update (Sales, EBITDA development), Outlook (2018 and Mid-term targets), and Growth Initiatives. This structure is characteristic of materials presented during an earnings call or an investor presentation following the release of interim financial results. Since it is a detailed presentation summarizing H1 (Half-Year) results, it aligns best with the Investor Presentation (IP) category, which covers detailed presentations focusing on financials and strategy. It is more detailed than a simple Earnings Release (ER) and is clearly a presentation format, not a transcript (CT) or a formal regulatory report like 10-K or IR.
2018-08-15 English
Präsentation zum Halbjahresbericht 2018
Investor Presentation Classification · 98% confidence The document is titled "H1 2018 Results Conference Call" and contains detailed slides covering a Business Update, Financial Update (Sales, EBITDA development), Outlook (2018 and Mid-term targets), and Growth Initiatives. This structure is characteristic of materials presented during an earnings call or an investor presentation following the release of interim financial results. Since it is a detailed presentation summarizing H1 (Half-Year) results, it aligns best with the Investor Presentation (IP) category, which covers detailed presentations focusing on financials and strategy. It is more detailed than a simple Earnings Release (ER) and is clearly a presentation format, not a transcript (CT) or a formal regulatory report like 10-K or IR.
2018-08-15 German
Half-Year Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half Year Report 2018' for the Zur Rose Group. It contains comprehensive financial statements, including the Consolidated Income Statement, Statement of Comprehensive Income, and Consolidated Balance Sheet for the period ending June 30, 2018. It also includes a letter to shareholders and management commentary. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. H2 2018
2018-08-15 English
Halbjahresbericht 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halbjahresbericht 2018' (Half-Year Report 2018) for the Zur Rose Group. It contains comprehensive financial statements, including the consolidated income statement, balance sheet, and cash flow statement for the period ending June 30, 2018. As it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H2 2018
2018-08-15 German
Zur Rose Group AG: Acquisition of the Spanish marketplace platform Promofarma
M&A Activity Classification · 99% confidence The document is a 'News Details' release from Zur Rose Group AG, dated August 2, 2018, announcing the acquisition of the Spanish marketplace platform Promofarma. It details strategic rationale, business models, and future plans. This type of announcement, concerning corporate strategy, expansion, and M&A activity, is best classified under the 'M&A Activity' category (TAR). It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a report publication announcement (RPA), as it is the primary announcement of the transaction itself.
2018-08-02 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.